FDA
-
-
-
-
-
-
-
La Jolla Pharmaceutical (LJPC) Announces $10M Share Repurchase Plan
-
-
-
-
-
-
-
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Corporate Progress
-
-
-
-
-
-
-
Pre-Open Movers 08/25: (OVID) (GPS) (CRM) Higher; (PLCE) (POR) (PANW) Lower (more...)
-
-
-
-
-
-
-
La Jolla Pharmaceutical Company Announces Financial Results for the Three Months Ended March 31, 2020
-
-
-
-
-
-
-
La Jolla Pharmaceutical Company to Provide GIAPREZA™ (Angiotensin II) for Named Patient Emergency Use in Patients with Septic Shock Due to COVID-19 at Guy’s and St. Thomas’ NHS Foundation Trust,
-
-
-
-
-
-
-
La Jolla to Reassess Continued Development of LJPC-401 Based on Recent Clinical Results
-
-
-
-
-
-
-
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Six Months Ended June 30, 2019 and Highlights Recent Corporate Progress
-
322,950 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

